Sushant Kamath Email & Phone Number | - Supporting launch of differentiated generic drug products for global regulatory markets (EMA, ANVISA, SFDA and CDSCO). - Providing support through toxicological risk assessment, impurity qualification studies as per ICH requirements. - Designing and coordinating nonclinical safety/bridging studies to support product safety. - Expertise in Nitrosamine Risk Assessment in API and Finished Products. - In-Silico and computational toxicology through QSAR and Read-Across approaches. - Establishing new approach methods (NAMs) and alternative drug testing strategies in line with 3Rs principles.

Sushant Kamath

- Supporting launch of differentiated generic drug products for global regulatory markets (EMA, ANVI...
Mumbai, Maharashtra, India

*50 free lookup(s) per month.

Sushant Kamath’s Email skamath@abbott.com

Sushant Kamath’s Phone Numbers

Get SUSHANT’s Phone Number (For Free)

Social Media

Sushant Kamath’s Location Mumbai, Maharashtra, India

Sushant Kamath’s Current Industry Abbott

Sushant Kamath’s Prior Industry Gvk Bio | Centre For Nanotechnology And Advanced Biomaterials | Manipal Acunova

Find accurate emails & phone numbers for over 700M professionals.

Senior Manager - Risk Assessment (Toxicology) Global Preclinical And Product Safety

2021-05-01 00:00:00 - Present

Scientific Manager

2016-06-01 00:00:00 - 2018-01-01 00:00:00

Research Scholar

2010-08-01 00:00:00 - 2015-07-01 00:00:00

Quality Assurance Associate (Ba/Be Studies)

2009-01-01 00:00:00 - 2010-01-01 00:00:00

No Skills Available

No Languages Available

Sushant Kamath is a - Supporting launch of differentiated generic drug products for global regulatory markets (EMA, ANVISA, SFDA and CDSCO). - Providing support through toxicological risk assessment, impurity qualification studies as per ICH requirements. - Designing and coordinating nonclinical safety/bridging studies to support product safety. - Expertise in Nitrosamine Risk Assessment in API and Finished Products. - In-Silico and computational toxicology through QSAR and Read-Across approaches. - Establishing new approach methods (NAMs) and alternative drug testing strategies in line with 3Rs principles.